CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
4.230
+0.020 (0.48%)
Mar 17, 2025, 3:05 PM EDT - Market open
CARGO Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 43.97 | 20.92 | 5.4 | 1.52 |
| Research & Development | 143.4 | 75.79 | 29.37 | 4.46 |
| Operating Expenses | 187.37 | 96.71 | 34.77 | 5.98 |
| Operating Income | -187.37 | -96.71 | -34.77 | -5.98 |
| Interest Expense | - | -1.6 | -4.94 | - |
| Interest & Investment Income | 20.06 | 4.87 | - | - |
| Other Non Operating Income (Expenses) | -0.2 | -2.39 | -1.24 | 0.13 |
| EBT Excluding Unusual Items | -167.5 | -95.83 | -40.95 | -5.85 |
| Other Unusual Items | - | -2.32 | - | - |
| Pretax Income | -167.5 | -98.15 | -40.95 | -5.85 |
| Net Income | -167.5 | -98.15 | -40.95 | -5.85 |
| Net Income to Common | -167.5 | -98.15 | -40.95 | -5.85 |
| Shares Outstanding (Basic) | 45 | 6 | 0 | 0 |
| Shares Outstanding (Diluted) | 45 | 6 | 0 | 0 |
| Shares Change (YoY) | 657.22% | 1413.96% | 157.33% | - |
| EPS (Basic) | -3.72 | -16.53 | -104.40 | -38.38 |
| EPS (Diluted) | -3.72 | -16.53 | -104.40 | -38.38 |
| Free Cash Flow | -144.19 | -89.44 | -31.8 | -5.38 |
| Free Cash Flow Per Share | -3.21 | -15.06 | -81.06 | -35.32 |
| EBITDA | -184.71 | -95.22 | -34.37 | -5.96 |
| D&A For EBITDA | 2.66 | 1.49 | 0.4 | 0.02 |
| EBIT | -187.37 | -96.71 | -34.77 | -5.98 |
Source: S&P Capital IQ. Standard template.
Financial Sources.